000 | 01675 a2200505 4500 | ||
---|---|---|---|
005 | 20250511213308.0 | ||
264 | 0 | _c19911226 | |
008 | 199112s 0 0 eng d | ||
022 | _a1043-3074 | ||
024 | 7 |
_a10.1002/hed.2880130507 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVikram, B | |
245 | 0 | 0 |
_aChemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: a feasibility study. _h[electronic resource] |
260 |
_bHead & neck _c |
||
300 |
_a415-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypopharyngeal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Recurrence, Local |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMalamud, S | |
700 | 1 | _aGold, J | |
700 | 1 | _aNussbaum, M | |
700 | 1 | _aKimmelman, C | |
700 | 1 | _aLucente, F | |
700 | 1 | _aPavlou, W | |
700 | 1 | _aPisch, J | |
700 | 1 | _aChadha, M | |
700 | 1 | _aBeattie, E | |
773 | 0 |
_tHead & neck _gvol. 13 _gno. 5 _gp. 415-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hed.2880130507 _zAvailable from publisher's website |
999 |
_c1944556 _d1944556 |